OBJECTIVE: To examine the association between changes in depressive symptoms and disability status in patients with diabetes. METHODS: This 5-year prospective cohort study included 2733 patients with diabetes enrolled in the Pathways Epidemiologic Follow-Up Study who had completed depression and activities of daily living questionnaires at baseline and 5 years. Four depression groups were created using changes in depression scores over 5 years: no depression, improved depression, persistent depression, and development of depression. After controlling for sociodemographic and clinical characteristics, we examined the association between changes in depressive symptoms and incident disability at 5 years using Poisson regression. RESULTS: In patients nondisabled at baseline (n = 2155), the improved depression group had a risk of disability comparable to the no depression reference group [relative risk (RR): 0.70, 95% CI (0.44-1.12)]. The development of depression and persistent depression groups were significantly more likely to develop disability compared with the no depression group [RR: 2.86, 95% CI (2.12-3.86) and RR: 2.16, 95% CI (1.47-3.18), respectively]. Among those who were disabled at baseline, there was no significant change in the disability status of the three depression groups compared with disabled patients with no depressive symptoms at either time point. CONCLUSIONS: Among initially nondisabled patients with diabetes, those whose depression improved had functional outcomes comparable to those who were nondepressed at baseline and 5 years. Patients who developed depression and had persistent depression were more likely to experience disability at 5 years than those who were nondepressed at baseline and 5 years.
OBJECTIVE: To examine the association between changes in depressive symptoms and disability status in patients with diabetes. METHODS: This 5-year prospective cohort study included 2733 patients with diabetes enrolled in the Pathways Epidemiologic Follow-Up Study who had completed depression and activities of daily living questionnaires at baseline and 5 years. Four depression groups were created using changes in depression scores over 5 years: no depression, improved depression, persistent depression, and development of depression. After controlling for sociodemographic and clinical characteristics, we examined the association between changes in depressive symptoms and incident disability at 5 years using Poisson regression. RESULTS: In patients nondisabled at baseline (n = 2155), the improved depression group had a risk of disability comparable to the no depression reference group [relative risk (RR): 0.70, 95% CI (0.44-1.12)]. The development of depression and persistent depression groups were significantly more likely to develop disability compared with the no depression group [RR: 2.86, 95% CI (2.12-3.86) and RR: 2.16, 95% CI (1.47-3.18), respectively]. Among those who were disabled at baseline, there was no significant change in the disability status of the three depression groups compared with disabled patients with no depressive symptoms at either time point. CONCLUSIONS: Among initially nondisabled patients with diabetes, those whose depression improved had functional outcomes comparable to those who were nondepressed at baseline and 5 years. Patients who developed depression and had persistent depression were more likely to experience disability at 5 years than those who were nondepressed at baseline and 5 years.
Authors: E J Lenze; J C Rogers; L M Martire; B H Mulsant; B L Rollman; M A Dew; R Schulz; C F Reynolds Journal: Am J Geriatr Psychiatry Date: 2001 Impact factor: 4.105
Authors: Wayne J Katon; Elizabeth H B Lin; Michael Von Korff; Paul Ciechanowski; Evette J Ludman; Bessie Young; Do Peterson; Carolyn M Rutter; Mary McGregor; David McCulloch Journal: N Engl J Med Date: 2010-12-30 Impact factor: 91.245
Authors: Paul A Fishman; Michael J Goodman; Mark C Hornbrook; Richard T Meenan; Donald J Bachman; Maureen C O'Keeffe Rosetti Journal: Med Care Date: 2003-01 Impact factor: 2.983
Authors: K B Wells; A Stewart; R D Hays; M A Burnam; W Rogers; M Daniels; S Berry; S Greenfield; J Ware Journal: JAMA Date: 1989-08-18 Impact factor: 56.272
Authors: Wayne Katon; Michael von Korff; Paul Ciechanowski; Joan Russo; Elizabeth Lin; Gregory Simon; Evette Ludman; Edward Walker; Terry Bush; Bessie Young Journal: Diabetes Care Date: 2004-04 Impact factor: 19.112
Authors: Rita Rastogi Kalyani; Nan Ji; Mercedes Carnethon; Alain G Bertoni; Elizabeth Selvin; Edward W Gregg; Mario Sims; Sherita Hill Golden Journal: J Diabetes Complications Date: 2017-03-09 Impact factor: 2.852
Authors: Hsiang Huang; Paulo R Menezes; Simone A da Silva; Karen Tabb; Andres Barkil-Oteo; Marcia Scazufca Journal: Gen Hosp Psychiatry Date: 2013-11-15 Impact factor: 3.238
Authors: Marcia Scazufca; Maria Clara P de Paula Couto; Hsiang Huang; Rachel Kester; Patrícia Emília Braga; Érica T P Peluso; Sérgio L Blay; Paulo R Menezes; Euler E Ribeiro Journal: PLoS One Date: 2016-06-28 Impact factor: 3.240
Authors: Marcia Scazufca; Maria Clara P de Paula Couto; Maiara Garcia Henrique; Ana Vilela Mendes; Alicia Matijasevich; Paula Carvalho Pereda; Renato M Franzin; Antônio Carlos Seabra; Pepijn van de Ven; William Hollingworth; Tim J Peters; Ricardo Araya Journal: BMC Public Health Date: 2019-08-22 Impact factor: 3.295
Authors: Pepijn Van de Ven; Ricardo Araya; Maria Clara P de Paula Couto; Maiara Garcia Henrique; Damien Meere; Ana Vilela Mendes; Tim J Peters; Antônio Seabra; Renato M Franzin; Paula Carvalho Pereda; Marcia Scazufca Journal: J Med Internet Res Date: 2019-11-12 Impact factor: 5.428